Education
About Us
Working with TipRanks
Follow Us
Eisai Co Ltd (JP:4523)
:4523
4523 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥3,463.00 - ¥7,110.00
Previous CloseN/A
Volume1.20M
Average Volume (3M)1.57M
Market Cap
$1.20T
Enterprise Value¥1.17T
Total Cash (Recent Filing)¥69.64B
Total Debt (Recent Filing)¥409.81B
Price to Earnings (P/E)20.6
Beta0.79
Next Earnings
May 15, 2025EPS Estimate
18.38Last Dividend Ex-Date
Mar 28, 2025Dividend Yield3.47%
Share Statistics
EPS (TTM)84.01
Shares Outstanding291,649,140
10 Day Avg. Volume984,970
30 Day Avg. Volume1,565,080
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5,109.43Price Target Upside25.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Eisai Co News
PremiumCompany Announcements
Eisai Co. Reports Cautious Optimism Amid Q3 Growth
PremiumPre-Earnings
Eisai Co (ESALF) Q2 Earnings Cheat Sheet
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
9.50%
Mutual Funds
0.08% Other Institutional Investors
81.63% Public Companies and
Individual Investors
4523 FAQ
What was Eisai Co Ltd’s price range in the past 12 months?
Eisai Co Ltd lowest stock price was ¥3463.00 and its highest was ¥7110.00 in the past 12 months.
What is Eisai Co Ltd’s market cap?
Eisai Co Ltd’s market cap is $1.20T.
When is Eisai Co Ltd’s upcoming earnings report date?
Eisai Co Ltd’s upcoming earnings report date is May 15, 2025 which is in 6 days.
How were Eisai Co Ltd’s earnings last quarter?
Eisai Co Ltd released its earnings results on Feb 07, 2025. The company reported ¥84.01 earnings per share for the quarter, beating the consensus estimate of ¥42.655 by ¥41.355.
Is Eisai Co Ltd overvalued?
According to Wall Street analysts Eisai Co Ltd’s price is currently Undervalued.
Does Eisai Co Ltd pay dividends?
Eisai Co Ltd pays a Annually dividend of ¥80 which represents an annual dividend yield of 3.47%. See more information on Eisai Co Ltd dividends here
What is Eisai Co Ltd’s EPS estimate?
Eisai Co Ltd’s EPS estimate is 18.38.
How many shares outstanding does Eisai Co Ltd have?
Eisai Co Ltd has 291,649,140 shares outstanding.
What happened to Eisai Co Ltd’s price movement after its last earnings report?
Eisai Co Ltd reported an EPS of ¥84.01 in its last earnings report, beating expectations of ¥42.655. Following the earnings report the stock price went up 0.111%.
Which hedge fund is a major shareholder of Eisai Co Ltd?
Currently, no hedge funds are holding shares in JP:4523
---
Company Description
Eisai Co Ltd
Eisai Co., Ltd. (4523) is a leading global pharmaceutical company headquartered in Tokyo, Japan. The company operates primarily in the pharmaceutical sector, focusing on the research, development, production, and marketing of a wide range of prescription medicines. Eisai's core therapeutic areas include neurology and oncology, with flagship products such as Aricept, used for the treatment of Alzheimer's disease, and Lenvima, an oncology medication. The company is committed to addressing unmet medical needs and improving the quality of life for patients worldwide.
---
4523 Company Deck
---
4523 Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a cautiously optimistic outlook with positive growth in revenue and pharmaceutical business, alongside challenges in profit margins and LEQEMBI market penetration goals. While the company's financial health and strategic developments are promising, immediate challenges exist in achieving short-term targets and managing expenses.Read More>---
4523 Stock 12 Month Forecast
Average Price Target
¥5,109.43
▲(25.66% Upside)
Technical Analysis
Nippon Shinyaku Co., Ltd.
―
Chugai Pharmaceutical Co
―
Shionogi & Co
―
Takeda Pharmaceutical Co
―
Daiichi Sankyo Company
―
---